{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T09:41:47Z","timestamp":1702028507371},"reference-count":27,"publisher":"Media Sphere Publishing Group","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2017]]},"DOI":"10.17116\/oftalma2017133175-80","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T09:47:42Z","timestamp":1489744062000},"page":"75","source":"Crossref","is-referenced-by-count":4,"title":["Staged complex treatment of paralytic lagophthalmos (case report)"],"prefix":"10.17116","volume":"133","author":[{"given":"M. B.","family":"Gushchina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Mal\u2019kov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Kovshun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Yuzhakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2017133175-80-1","unstructured":"Agafonova EI, Grusha YO. Surgical treatment options for paralytic lagophthalmos. Vestnik oftal\u2019moljgii. 2010;126(5):48-52. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9290.80002"},{"key":"key-10.17116\/oftalma2017133175-80-3","unstructured":"Saksonova EV, Orlova OR, Kurenkov AL. The functional asymmetry of the facial neuromotor apparatus in patients with facial nerve neuropathy and its treatment with botulinum toxin type A lantox. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;10:29-35. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-4","unstructured":"Grusha YO. Conceptual basics of paralytic lagophthalmos correction. Vestnik oftal\u2019moljgii. 2013;129(5):92-96. (In Russ)."},{"key":"key-10.17116\/oftalma2017133175-80-5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1075838"},{"key":"key-10.17116\/oftalma2017133175-80-6","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2010.488578"},{"key":"key-10.17116\/oftalma2017133175-80-7","unstructured":"Grusha YO, Ivanchenko IuF, Sherstneva LV. Static correction of lagophthalmos in chronic facial palsy. Vestnik oftal\u2019moljgii. 2012;128(3):25-29. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-8","unstructured":"Ivanchenko IuF. Khirurgicheskaya korrektsiya lagoftal'ma pri khronicheskom paraliche litsevogo nerva. Diss. kand. med. nauk. Moscow, 2011. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-9","unstructured":"Tiemstra JD, Khatkhate N. Bell's palsy: diagnosis and management. Am Fam Physician. 2007;76(7):997-1002."},{"key":"key-10.17116\/oftalma2017133175-80-10","unstructured":"Tabashnikova TV, Serova NK, Shimanskii VN, Grigor'eva NN. Botulotoxin type A (lantox) for inducing temporal ptosis in neurosurgical patients. Zhurnal voprosy neirokhirurgii im. N.N. Burdenko. 2012;4:43-48. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-11","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.63078"},{"key":"key-10.17116\/oftalma2017133175-80-12","unstructured":"Grusha YO, Ismailova DS, Ivanchenko IuF, Agafonova EI. The first experience in using the stabilized hyaluronic acid preparation to correct lagophthalmos. Vestnik oftal\u2019moljgii. 2010;126(1):39-42. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-13","unstructured":"Kasparov AA, Kasparova EA, Sobkova OI. Treatment for central corneal ulcer in the presence of lagophthalmos by autoconjunctivoplasty in combination with optic iridectomy and external blepharorrhaphy a clinical case. Vestnik oftal\u2019moljgii. 2010;126(2):35-37. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-14","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318192568d"},{"key":"key-10.17116\/oftalma2017133175-80-15","doi-asserted-by":"crossref","unstructured":"Snyder MC, Johnson PJ, Moore GF, Ogren FP. Early versus late gold weight implantation for rehabilitation of the paralyzed eyelid. Laryngoscope. 2001;111:2109-2113.","DOI":"10.1097\/00005537-200112000-00005"},{"key":"key-10.17116\/oftalma2017133175-80-16","doi-asserted-by":"crossref","unstructured":"Ladnaya ID. Efficiency of treatment of facial neuropathy by reflexotherapy. Bukovins'kii medichnii v\u0456snik. 2015;1:92-96. (In Ukr.).","DOI":"10.24061\/2413-0737.XIX.1.73.2015.21"},{"key":"key-10.17116\/oftalma2017133175-80-17","unstructured":"Orlova OR. Opportunities and prospects of using of botulinum toxin in clinical practice. Russkii meditsinskii zhurnal. 2006;14(23):3-10. (In Russ.)."},{"key":"key-10.17116\/oftalma2017133175-80-18","doi-asserted-by":"crossref","unstructured":"Shih MJ, Liao SL, Lu HY. A single transcutaneous injection with Botox for dysthyroid lid retraction. Eye (Lond). 2004;18(5):466-469.","DOI":"10.1038\/sj.eye.6700690"},{"key":"key-10.17116\/oftalma2017133175-80-19","doi-asserted-by":"crossref","unstructured":"Chua CN, Quhill F, Jones E, Voon LW, Ahad M, Rowson N. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. 2004;23(4):213-218.","DOI":"10.1080\/01676830490512233"},{"key":"key-10.17116\/oftalma2017133175-80-20","doi-asserted-by":"crossref","unstructured":"Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis. Clin Experiment Ophthalmol 2001;29(6):394-399.","DOI":"10.1046\/j.1442-9071.2001.d01-28.x"},{"key":"key-10.17116\/oftalma2017133175-80-21","doi-asserted-by":"crossref","unstructured":"Gusek-Schneider GC, Erbguth F. Protective ptosis by botulinum A toxin injection in corneal affectations. Klin Monbl Augenheilkd. 1998;213(1):15-22.","DOI":"10.1055\/s-2008-1034938"},{"key":"key-10.17116\/oftalma2017133175-80-22","doi-asserted-by":"publisher","DOI":"10.4103\/2090-0686.134937"},{"key":"key-10.17116\/oftalma2017133175-80-23","doi-asserted-by":"crossref","unstructured":"Adams GG, Kirkness CM, Lee JP. Botulinum toxin A induced protective ptosis. Eye (Lond). 1987;1(Pt 5):603-608.","DOI":"10.1038\/eye.1987.93"},{"key":"key-10.17116\/oftalma2017133175-80-24","doi-asserted-by":"crossref","unstructured":"Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology. 1988;95(4):473-480.","DOI":"10.1016\/S0161-6420(88)33163-5"},{"key":"key-10.17116\/oftalma2017133175-80-25","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31824ee702"},{"key":"key-10.17116\/oftalma2017133175-80-26","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2010.03.13"},{"key":"key-10.17116\/oftalma2017133175-80-27","doi-asserted-by":"crossref","unstructured":"Naik MN, Gangopadhyay N, Fernandes M, Murthy R, Honavar SG. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye (Lond). 2008;22(9):1132-1136.","DOI":"10.1038\/sj.eye.6702866"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:52:33Z","timestamp":1692726753000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2017\/1\/downloads\/ru\/10042465X2017011075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["oftalma2017133175-80"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2017133175-80","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}